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Abstract
The molecular mechanisms underlying prostate carcinogenesis are poorly understood. Prostatic acid phosphatase (PAP), a
prostatic epithelial secretion marker, has been linked to prostate cancer since the 1930’s. However, the contribution of PAP
to the disease remains controversial. We have previously cloned and described two isoforms of this protein, a secretory
(sPAP) and a transmembrane type-I (TMPAP). The goal in this work was to understand the physiological function of TMPAP
in the prostate. We conducted histological, ultra-structural and genome-wide analyses of the prostate of our PAP-deficient
mouse model (PAP2/2) with C57BL/6J background. The PAP2/2 mouse prostate showed the development of slow-growing
non-metastatic prostate adenocarcinoma. In order to find out the mechanism behind, we identified PAP-interacting
proteins byyeast two-hybrid assays and a clear result was obtained for the interaction of PAP with snapin, a SNARE-
associated protein which binds Snap25 facilitating the vesicular membrane fusion process. We confirmed this interaction by
co-localization studies in TMPAP-transfected LNCaP cells (TMPAP/LNCaP cells) and in vivo FRET analyses in transient
transfected LNCaP cells. The differential gene expression analyses revealed the dysregulation of the same genes known to
be related to synaptic vesicular traffic. Both TMPAP and snapin were detected in isolated exosomes. Our results suggest that
TMPAP is involved in endo-/exocytosis and disturbed vesicular traffic is a hallmark of prostate adenocarcinoma.
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Introduction
The association between prostate cancer and serum prostatic
acid phosphatase (PAP; ACPP; EC 3.1.3.2) has been known for
more than 70 years [1]. Nevertheless, the molecular mechanisms
underlying this association are still poorly understood. In spite of
this, the connection between secreted PAP and prostate cancer
contributed to the development of Sipuleucel-T, the first FDA-
approved vaccine for cancer therapy targeting PAP-expressing
cells [2] even when in advanced/androgen-independent prostate
cancer tissue, the expression of PAP is down-regulated [3].
Therefore, our goal is to elucidate the pathways where PAP and in
particular its transmembrane isoform is involved.
PAP is a histidine acid phosphatase [4] from which two isoforms
have been cloned, the secreted (sPAP) and the transmembrane
type-I (TMPAP). Both are splice-variants of the same gene and
widely expressed in different tissues, in both sexes [5]. The current
evidence does not support the existence of a third, cytosolic
cellular form of PAP, as it has been suggested in the literature but
never cloned [6–8]. Topologically, TMPAP contains an N-
terminal phosphatase activity domain which is extracellular when
TMPAP is in the plasma membrane and intra-luminal when it is
trafficking in vesicles, and a C-terminal domain with a cytosolic
tyrosine-based endosomal-lysosomal (including MVE) targeting
signal motif (YxxW) [5]. TMPAP also co-localizes with flotillin and
LAMP2 [5], which are known markers for exosomes [9,10].
The prostate gland is fundamentally a secretory organ, and it is
known that the secretion of specialized exosomes (prostasomes) is
essential for the maintenance of the spermatozoa [11]. Exosomes
are nanovesicles originated from multivesicular endosomes (MVE),
which contain protein, lipid, DNA, RNA and/or microRNA
molecules [12]. Also, it has been shown that exosomes are involved
in the promotion of cancer cell proliferation and survival [13], and
an increased level of prostasomes (exosomes) has been detected in
plasma of prostate cancer patients [14].
PAP exerts its phosphatase activity in vitro against b-glycero-
phosphate [15], lysophosphatidic acid [16], and phosphoamino
acids [17] and has 59-nucleotidase activity [18]. In vivo, the ecto-59-
PLOS ONE | www.plosone.org 1 September 2013 | Volume 8 | Issue 9 | e73072
nucleotidase activity of PAP is responsible of dephosphorylating
adenosine monophosphate (AMP) to adenosine [18,19] leading to
the activation of A1-adenosine receptors in the dorsal root ganglia
(DRG) [19]. PAP regulates the levels of adenosine and
phosphatidylinositol 4,5-bisphosphate [PI (4,5) P2], an essential
regulator of vesicular traffic [20], reducingsensitivity to painful
stimuli [19,21].
SNARE proteins comprise a large family found in yeast and
mammalian cells, with the primary function to mediate docking
and fusion of vesicles with the cell membranes [22] in regulated
endo-/exocytosis [23]. Snapin is a SNARE-associated protein [24]
interacting with Snap25, Snap23 or Snap29, and increasing the
binding of the calcium sensor synaptotagmin to the SNARE
complex [25]. Snapin also forms part of the BLOC1 protein
complex, which is necessary for the biogenesis of vesicles in the
endosomal-lysosomal pathway [26]. Increasing evidence shows
that snapin is important in retrograde axonal transport, late
endosomal-lysosomal trafficking and glucose-induced insulin
exocytosis. In mediating retrograde axonal transport, snapin acts
as a dynein adaptor protein for BDNF-TrkB (brain-derived
neurotrophic factor – tyrosine kinase receptor B) activated
signaling complexes. This interaction leads to the delivery of
TrkB signaling endosomes from axonal terminals to cell bodies,
which is an essential mechanism for dendritic growth of cortical
neurons [27]. Moreover, snapin deficiency in neurons leads also to
accumulation of immature lysosomes due to impaired delivery of
cargo proteins from late endosomes to lysosomes [28]. In addition,
snapin as a target of protein kinase A (PKA), was found to be a
critical regulator of glucose-stimulated insulin exocytosis in
pancreatic b-cells by promoting the interaction and assembly of
insulin secretory vesicle-associated proteins Snap25, collectrin and
Epac2 [29].
The mouse prostate consists of three different lobes: anterior
(AP), dorsolateral (DLP) and ventral prostate (VP); and it does not
show spontaneous development of neoplasia [30]. The mouse
prostate lobes have characteristic histology which has been
described previously [31,32]. Briefly, all prostate lobes show a
monolayer epithelium with eosinophilic columnar cells and
eosinophilic secretion which is paler in VP than in AP and DLP.
Each ductin the lobes is surrounded by a thin fibromuscular sheet
composed mainly of smooth muscle cells and collagen fibers. In
the AP epithelium, the cell nucleus is central and the epithelium
has a high number of infoldings and papillary structures. The DLP
epithelium has central to basal nucleus and a moderate degree of
infolding. The VP epithelium is characterized by basal nucleus
and focal infoldings.
To understand the physiological function of PAP, we studied the
prostate of our PAP-deficient mouse model (PAP2/2) [33]. The
PAP2/2 mouse prostate showed disturbed vesicular trafficking,
loss of cell polarity and development of slow-growing non-
metastatic prostate adenocarcinoma. Here we report the interac-
tion of TMPAP with snapin; and suggest that TMPAP regulates
endo-/exocytosis and the disruption of these processesis a
hallmark of prostate adenocarcinoma.
Materials and Methods
Ethics statement
The animal protocols were approved by the Animal Experi-
mentation Committee of the University of Oulu and ELLA – The
National Animal Experiment Board of Finland. The project
license numbers are 044/11 and STH705A/ESLH-2009–08353/
Ym-2.
Mice
Mice deficient in PAP were generated by replacing exon 3
(ACPPD3/D3) of the prostatic acid phosphatase gene (ACPP, PAP)
with the neo gene as described earlier [33] thereby abolishing
the expression of both PAP isoforms. The fertility status in the
PAP2/2 mice was not affected by the gene modification. PAP2/2
mice were backcrossed to the C57BL/6J strain (Harlan Labora-
tories Inc.) for 16 generations to obtain homogenous background.
Age-matched C57BL/6J male mice were used as controls in all the
experiments.
Figure 1. DLP lobeexhibits the primary changes in the PAP2/2 mouse prostate. The panels show an overview of the 12 month-old mice
prostate dissected lobes. The DLP, AP and VP lobes were dissected from WT and PAP2/2 mouse. The monolayer epithelium (white arrows) is seen in
all the lobes of the WT mouse, whereas in the PAP2/2 mouse an increased amount of cells is present in the lumen of the DLP lobe (black arrows). The
AP and VP of PAP2/2 mouse show no significant changes. Scale bars: 100 mm.
doi:10.1371/journal.pone.0073072.g001
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Figure 2. PAP2/2 mice develop prostate adenocarcinoma. A, age related histological changes in PAP2/2 mouse DLP. Epithelial hyperplasia
was present in DLP of 3 month-old PAP2/2 mice. The lumen was filled with dysplastic epithelial cells, and mPIN structures were observed in 6 month-
old animals. Bulging of epithelial cells into the stroma (black arrows) through loosen fibromuscular sheath and prostate adenocarcinoma were
present in 12 month-old mice. Scale bars: 100 mm. (n= 8). B, morphological abnormalities present in 12 month-old PAP2/2 mouse prostates. Glands
TMPAP Interacts with Snapin
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were filled with epithelial cells (black arrow head). Dyscohesive cells with double nuclei were present (white arrows), as well as sites of microinvasions
of hyperchromatic epithelial cells with prominent nucleoli (black arrow). Cribriform structures (white arrowhead) and blood vessels among neoplastic
epithelial cells (*) were also observed. Scale bars: 100 mm. (n= 8). C, 24 month-old PAP2/2 mouse DLPs. Cells invaded the surrounding stroma and
inflammation is present. Microinvasion of cells into the stroma and bulging is clearly observed (black arrows). Scale bars: 100 mm. (n= 8). FS:
fibromuscular sheath, L: lumen, mL: monolayer epithelium.
doi:10.1371/journal.pone.0073072.g002
Figure 3.The prostate adenocarcinoma in PAP2/2 mice is also detected by immunohistochemistry and electronmicroscopy. A,
smooth muscle actin (SMA) immunohistochemistry in 12 month-old mice. Monolayer epithelium (mL) and open lumen in PAP+/+ DLP. White arrows
show the broken fibromuscular sheath (SM, smooth muscle) and bulging of epithelial cells to the stroma. Prostate adenocarcinoma (black arrows) is
present in AP and DLP, showing a multilayer epithelium (ML) and inflammatory cells (black arrowhead) spreading in neighboring areas. Scale bars:
100 mm. (n= 4, per group). B, ultrastructural changes in 3 month-old and 12 month-old PAP2/2 mouse DLPs. Monolayer epithelium, regular
basement membrane (BM) and apical secretion are clearly seen in PAP+/+ mouse DLPs. 3 month-old PAP2/2 DLPs show irregular BM and numerous
apical vacuoles (red arrow head), as well the presence of basal lysosomes (Ly). In 12 month-old PAP2/2 mouse DLPs, the epithelium has transformed
to a multilayer epithelium containing hyperchromatic nuclei with multiple nucleoli. Pseudolumens (pL) have formed as a result of the growing and
fusion of the epithelium. Invaginations of BM (red arrows) into the epithelium and numerous vesicles in the basal side of the cells (blue arrow heads)
were additional signs of the transformation in the cells. Scale bars: 2000 nm (n= 4, per group).
doi:10.1371/journal.pone.0073072.g003
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Transmission electron microscopy
DLP samples from age-matched PAP2/2 and PAP+/+ mice
were fixed in a mixture of 1% glutaraldehyde and 4%
formaldehyde in 0.1 M phosphate buffer for TEM. The samples
were post-fixed in 1% osmium tetroxide, dehydrated in acetone,
embedded in Epon Embed 812 (Electron Microscopy Sciences)
and analyzed at the Biocenter Oulu EM core facility using Philips
100 CM Transmission Electron Microscope with CCD camera.
Yeast two-hybrid analysis
To screen for interacting partners of human TMPAP, yeast two-
hybrid screening was performed using the Matchmaker Gal4 two-
hybrid System 3 (Clontech) in accordance with the manufacturer’s
instructions. The bait construct consisted of the coding region of
human TMPAP (GeneBank accession BC007460, nucleotides 51–
1304, except the starting methionine was changed to valine)
cloned in frame into NcoI/SmaI sites of pGBKT7 using PCR
generated linkers. A human thymus cDNA library cloned in
pACT2 (Clontech) was used as the prey. The bait and prey
Figure 4. PAP2/2 mouse DLPs release exosomal-like microvesicles. A, electronmicroscopy images show the presence of electron-dense
(white arrow) and electron-lucent (black arrow) microvesicles (,30 to 80 nm) in the lumen of the acini, and MVE containing microvesicles in the
apical part of the cell. Scale bar: 1,000 nm. B, numerous microvesicles are present in the apical region of PAP2/2 DLP and secreted into the lumen,
decreased amount of microvilli is observed (black arrowheads) (scale bar: 1,000 nm). C, microvesicles are secreted into basolateral intercellular space
of PAP2/2 DLP (scale bar: 2000 nm). D, lamellar body-like structures (*) are inside the epithelial cell (scale bar: 500 nm) and E, released into the lumen
(*). Scale bar: 200 nm. F, TMPAP and snapin are also present in exosomes. Immunoblots of exosomes isolated from TMPAP/LNCaP cell culture
medium. Flotillin and CD13 were used as exosomal and prostasomal marker respectively.
doi:10.1371/journal.pone.0073072.g004
Figure 5. Proliferation of DLP cells is increased in PAP2/2 mice compared to WT mice. A, bar plot showing the ratio (as percentage)
between proliferative cell counts and total amount of cells. (**, P value ,0.01; ***, P value ,0.001). Error bars indicate S.E.M. values. B, bar plot
showing the ratio (as percentage) between apoptotic cell counts and total amount of cells. Error bars indicate S.E.M. values.
doi:10.1371/journal.pone.0073072.g005
TMPAP Interacts with Snapin
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plasmids were co-transformed into Saccharomyces cerevisiae Mav 203
strain according to the Clontech’s two-hybrid protocols. Inserts of
positive clones were amplified by PCR, and the DNA was
automatically sequenced.
The Fo¨ster resonance energy transfer (FRET) analysis
The FRET variant acceptor photobleaching was used. In this
technique, the efficiency of energy transfer between two molecules
(and consequently the interaction between them) is measured by
comparing the fluorescence of the donor molecule before and after
the selective photobleaching of the acceptor moleclule [34].
Human TMPAP-GFP and the control GFP plasmid constructs
have been previously described [5]. Human snapin (NM_012437,
nt 76–486) was cloned into pDsRed-Monomer-C1 vector,
between SalI/BamHI restriction sites. LNCaP cells were obtained
from the American Tissue Culture Collection (ATCC) and
Table 1. Significant ontological terms obtained with GoMiner software from two-color microarrays experiments.
GO ID P-value Term Genes
5576 ,0.0001 extracellular region
7268 ,0.0001 synaptic transmission Nrxn1, Htr3b, Edn1, Timp4, Syn2, Gria1, Tac1, Ncam1, Kif5a, Pnoc,
Snap25, Htr3a, Syp, Bcan, Rab3c, Syt10, Cplx1, Gad2, Syt4, Abpa, Grm7,
Rasgrf1, Cart, Syt1
43005 ,0.0001 neuron projection Gria1, Gria3, Tac1, Ncam1, Mapt, Kif5a, Uchl1, Esr2, Cntn2, Prph1, Nef3,
Ttyh1, Sncg, Syt4, Gad2, Nefl, Gap43, Syt1, Kif5c
45202 ,0.0001 synapse Nrxn1, Htr3b, Syn2, Thbs4, Gria1, Gria3, Snap25, Htr3a, Nef3, Syp,
Bcan, Syngr1, Syt10, Syt4, Gad2, Gabra4, Mgll, Grm7, Syt1
30424 ,0.0001 axon Ttyh1, Sncg, Tac1, Gad2, Ncam1, Mapt, Nefl, Gap43, Uchl1, Cntn2,
Prph1, Nef3
8021 ,0.0001 synaptic vesicle Syngr1, Timp4, Syn2, Syt10, Syt4, Svop, Rab3c, Syp, Bcan, Syt1
4293 ,0.0001 tissue kallikrein activity
42044 ,0.0001 fluid transport
32501 0.0001 multicellular organismal process
7267 0.0001 cell-cell signaling
19226 0.0001 transmission of nerve impulse Nrxn1, Timp4, Syn2, Pnoc, Htr3a, Cldn11, Rab3c, Cplx1, Gad2, Syt4, Grm7,
Rasgrf1, Edn1, Htr3b, Gria1, Ncam1, Tac1, Kif5a, Snap25, Syp, Bcan, Syt10,
Abpa, Cart, Syt1
3001 0.0001 generation of a signal involved in cell-cell signaling
45055 0.0001 regulated secretory pathway Nrxn1, Timp4, Lat, Syn2, Cplx1, Syt4, Abpa, Snap25, Cart, Rab3c, Syt1
30672 0.0001 synaptic vesicle membrane Syngr1, Syn2, Bcan, Syp, Syt1
15026 0.0001 coreceptor activity
5372 0.0001 water transporter activity
15250 0.0001 water channel activity
15722 0.0001 canalicular bile acid transport
5179 0.0002 hormone activity
7269 0.0002 neurotransmitter secretion Nrxn1, Timp4, Syn2, Cplx1, Syt4, Abpa, Snap25, Rab3c, Cart, Syt1
1772 0.0002 immunological synapse
6833 0.0003 water transport
31226 0.0005 intrinsic to plasma membrane Nrxn1, Treh, Aqp7, Kcnj5, Aqp9, Aqp5, Cldn11, Cntn2, Htr3a, Cd28,
Rhbg, Kcnc1, Lat, V1rc12, Itga9, Acvr1b, Aqp8, Tcrb-V13, Kcnv2,
Gabra4, Tpbg, Tyro3, Gp5, Slc12a2, Htr3b, Gria1, Gria3, P2rxl1, Mme,
Slco1a6, Abcb11, Snap25, Xtrp3s1, Cnr1, Adcy3, Raet1a, Syngr1, Cd5,
V1rg9, Mup1, Ptprj, Slc15a2, Omg, Adora1, Olfr43, Slco1a1
45104 0.0005 intermediate filament cytoskeleton organization and
biogenesis
Nefl, Krt6b, Prph1, Nef3
5883 0.0005 neurofilament Nefl, Prph1, Nef3
30136 0.0006 clathrin-coated vesicle Syngr1, Timp4, Syn2, Syt10, Syt4, Svop, Ncald, Bcan, Syp, Rab3c, Syt1
5232 0.0006 serotonin-activated cation-selective channel activity
5615 0.0007 extracellular space
48812 0.0007 neurite morphogenesis
48667 0.0007 neuron morphogenesis during differentiation
7409 0.0008 axonogenesis
GO ID: gene ontology ID accession number. P-value: P-value for the number of changed genes in the input list, significant P-value ,0.05. Term: associated ontological
term. Rows in bold: relevant ontological groups for vesicular transport. Mice in microarray experiment per group, n= 3.
doi:10.1371/journal.pone.0073072.t001
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cultured in 10% FBS (Promocell), L-Glutamine (2 mM), Penicillin
(100 U/ml), Streptomycin (100 mg/ml), RPMI-1640 (Sigma) on
polylysine-coated petridishes (Mattek). Cells were transfected using
Lipofectamine 2000 (Invitrogen) according to manufacturer’s
instructions. In our experiments we used GFP and DsRed
fluorophores as donor and acceptor, respectively, and co-
expressed TMPAP-GFP and snapin-DsRed plasmids in LNCaP
cells. GFP/DsRed FRET pair provides excellent wavelength
separation of donor and acceptor spectra. For FRET positive
control we used a DNA construct produced by the connection of
EGFP and DsRed sequences with a 23–amino acid linker. Co-
transfected pEGFP-C1 and pDsRed-Monomer-C1 vectors have
been used as negative controls.
Cultured cells were mounted 24 hours after transfection and
epifluorescent images were acquired using an Olympus CellR
imaging system with 606oil immersion NA 1.45 objective. Images
were collected with a CCD camera (Orca, Hamamatsu). The
system was equipped with automated filter wheels for excitation
filters and emission beam-splitter/emission-filter cubes for epi-
fluorescence imaging. GFP fluorescence was excited at 450 nm
and collected at 510/40 nm. DsRed fluorescence was excited at
575 nm and collected at 640/50 nm. Acceptor fluorescence was
bleached for 5 minutes with maximal burner power.
Figure 6. TMPAP co-localize and interact with snapin in the cell lamellipodia. A, co-localization (yellow) of TMPAP (green) with snapin (red)
was observed in the vesicles and lamellipodia of the TMPAP/LNCaP cells. Arrows mark the co-localization points in the upper panel (scale bar: 20 mm).
Lower panel (scale bar: 3 mm) showing the lamellipodia region, amplification of the area marked with a box in the upper panel (left). B, intensification
of donor (TMPAP-GFP) fluorescence in LNCaP cells was observed after acceptor (snapin-DsRed) photobleaching which confirms FRET between two
molecules (Scale bar: 2 mm).
doi:10.1371/journal.pone.0073072.g006
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Images were quantified and processed using Olympus Biosys-
tems AnalySIS software, ImageJ (freely available at http://rsb.
info.nih.gov/ij/) and ImagePro 5.1 (Media Cybernetics). Back-
ground fluorescence was subtracted prior to calculations. The
FRET efficacy defined as the percentage of donor fluorescence
increase was calculated with the following equation: E= 1-(Ib/Ia),
where ‘Ib’ is the fluorescence intensity of the donor before
photobleaching and ‘Ia’ is the post-bleach fluorescence intensity.
Histology, immunohistochemistry, proliferation and
apoptosis analyses, microarray analyses, generation of
stable transfected LNCaP cells, immunofluorescence and
co-localization studies, comparative genomic
hybridization (CGH), isolation of exosomes and Western
blot analyses
The detailed methodology can be found in the Supplementary
Methodology in File S1.
Accession codes
Gene expression files containing microarray raw-data can be
accessed from ArrayExpress repository database (accession num-
ber E-MTAB-1191).
Results
PAP-deficiency in mouse prostates leads to development
of prostate adenocarcinoma
PAP-deficiency led to slow development of prostate neoplasia in
DLP and AP. The progressive changes in mouse DLP were
observed in all the PAP2/2mice examined (n=8), detecting a
hyperplastic growth already at the age of 3 months, followed by
mouse prostatic intraepithelial neoplasia (mPIN) at 6 months and
prostate adenocarcinoma at 12 months (Fig. 1 and 2A). The
follow-up of the disease in mice spanned until 26 month-old,
where the presence of other pathologies arose as strain background
or due to mouse aging.
Figure 7. TMPAP is involved in endo-/exocytosis (proposed mechanism). TMPAP synthesized in the endoplasmic reticulum is transported in
vesicles to the plasma membrane through the trans-Golgi network (TGN). After the vesicle docking and fusion events leading to release of vesicle
content, TMPAP inserted in plasma membrane exerts its phosphatase function over AMP. The resulting product adenosine (Ado) activates the
adenosine receptors, which are GPCRs, A1 or A3with Gai (inhibitory G-protein b-subunit) specificity leading to the inhibition of adenylate cyclase (AC)
activity, and A2 adenosine receptors with Gas (stimulatory G-protein a-subunit) producing the stimulation of AC activity. Activated AC produces
cAMP, which activates PKA responsible for the phosphorylation of snapin. The turnover is completed by clathrin-mediated endocytosis of SNARE
components and TMPAP for recycling and degradation in lysosomes vı´a the endosomal-lysosomal pathway. From early endosomes, the cargo can be
sorted to late endosomes or to MVE, which can follow the route leading to exosome release. Additional dephosphorylation events by TMPAP can
occur while trafficking between different compartments. From late endosomes, TMPAP can go to lysosomes or back to TGN via the retrograde
pathway. ATP: adenosine triphosphate, ADP: adenosine diphosphate, AMP: adenosine monophosphate, Ado: adenosine, TGN: trans-Golgi network, P:
phosphate group, AP-2: adaptor protein complex 2, ADORA: adenosine receptor A (types A1, A2 and A3), AC: adenylate cyclase, Gas, Gai, Gb, Gc: G-
protein subunits, VDCC: Voltage-gated calcium channel. Synaptobrevin, syntaxin and SNAP25 are SNARE proteins. PI (4,5) P2: phosphatidylinositol 4,5-
bisphosphate.
doi:10.1371/journal.pone.0073072.g007
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All the PAP2/2mice analyzed at the age of 12 months had
developed prostate adenocarcinoma (n=8, Fig. 2B). Pathological
acini were filled with non-cohesive pleomorphic epithelial cells,
with enlarged hyperchromatic nuclei and prominent nucleoli. The
presence of neoplastic acinar cells in the lumen was confirmed
with pan cytokeratin staining (Fig. S1 in File S1). The fibrotic
stroma surrounding the acini appeared to be invaded by cells, with
bulging areas and fusion of acini. Cribriform structures were also
observed, additionally to numerous blood vessels among neoplastic
epithelial cells. The histological pattern was consistent with locally
invasive prostate adenocarcinoma. In the 24 month-old PAP2/2
mice, we observed an increasedamount of cells in the AP lumen
(Fig. 2A) and a clear invasion of the surrounding areas as well as
increased amount of inflammatory cells (n=5, Fig. 3C). However,
we did not detect metastatic lesions in other studied organs such as
brain, liver, lungs and lymph nodes at any age analyzed.
The breakdown of the fibromuscular sheath and invasion of the
epithelial cells into stroma were also detected with smooth muscle
b-actin (SMA) staining (Fig. 3A). Bulging of the cells could be seen
in atypical acini, as well as adenocarcinoma invasion. Crowding of
inflammatory cells was detected in sites of microinvasive adeno-
carcinoma.
Important changes observed by transmission electron micros-
copy (TEM) included irregularities and invaginations of the
basement membrane into the epithelium (Fig. 3B) in addition to
the presence of lysosomes and MVE in the basal side of the cell.
The prostatic epithelium of PAP2/2mice lost the regular structure
of uniform columnar monolayer transforming to a cuboidal
multilayer epithelium with hyperchromatic nuclei and presence of
pseudo-lumens as a sign of loss in cell polarity. Further analysis of
prostate ultrastructural changes showed an increased number of
electron-lucent enlarged vacuoles (Fig. 4A and B), and bursting of
luminal exosome-like vesicles of30–80 nm in diameter (Fig. 4B).
Exosome-like vesicles in the intercellular space and disintegration
of the apical microvilli, indicates also loss of cell polarity (Fig. 4B
and C). Lamellar body–like structures were observed in PAP2/2
mice DLP cells and their contents secreted into the lumen (Fig. 4D
and E).
Due to the gradually increased number of cells in the prostate
acini, we determined the status of proliferation and apoptosis in the
tissue. As a result, the proliferation was significantly increased in the
three- (P-value= 4.361023, n=4), six- (P-value= 1.3610215, n=4)
and 12 month-old (P-value= 3.961025, n=4) PAP2/2 mice DLP,
but the apoptosis status was not different between genotypes at the
same time points (P-values 0.3, 0.1, and 0.9 respectively, n=4) (Fig. 5
and Tables S1 – S4 in File S1).
PAP interacts with SNARE associated protein, snapin
To determine the effects of PAP deficiency at gene expression
level, we performed microarray experiments of mouse prostatic
tissue. The Gene Ontology analyses of differentially expressed
genes showed, among the most significant groups, those genes
associated with regulated secretory pathway, neurotransmitter
secretion (Snap25, Syt1, Syt4, Nrxn1, Cart, Abpa, Cplx1) and synaptic
vesicle traffic (Rab3c, Syp, Syn2, Syngr1, Syt1, Syt4, Syt10, Svop, Bcan,
Timp4) (Table 1 and Tables S5 and S6 in File S1). Comparative
genomic hybridization analysis of DNA prostate samples per-
formed at 6-, 15- and 25 month-old showed no differencies in
copy number between the genotypes (wild type C57BL/6J and
PAP2/2 mice, data not shown).
The disturbed exocytosis observed in the ultrastructural studies
of PAP2/2 prostates and the differential expression of genes
related to vesicle fusion, such as Snap25, Syt1, Syt4 and Cplx1, led us
to search for proteins interacting with TMPAP. The yeast two-
hybridization screening of human thymus library detected seven
out of 15 clones expressing snapin (NM_012437.3), as a clear
candidate for interaction with TMPAP.
To validate the yeast two-hybrid result, double-immunofluores-
cence staining of PAP and snapin in TMPAP/LNCaP cells
showed co-localization of these two proteins in vesicular structures
and cell membrane (Fig. 6A). The quantification studies displayed
relatively low Pearson’s correlation coefficient when the whole cell
was analyzed (0.48560.012). However, when the co-localization
was quantified exclusively in the cell lamellipodia the Pearson’s
correlation coefficient reached a value of 0.68060.013. This
coefficient value not only shows that TMPAP co-localized with
snapin but it could imply an interaction between TMPAP and
snapin in these cell regions. Therefore, to confirm this hypothesis
of interaction, the FRET variant acceptor photobleaching, which
gives an in vivo proof of the physical protein-protein interaction,
was used to determine the interaction between TMPAP and
snapin. Data analysis revealed significant FRET between TMPAP
and snapin (FRET efficacy 9.361%, n=12 cells) compared to
experiments with negative control (20.460.7%, n=9 cells,
P,0.0001) while in experiments with positive control FRET
efficacy reached a level of 37.766.5% (Fig. 6B).
Hence our previous results have showed the co-localization of
PAP and flotillin, which is a protein also used as exosomal marker
[9], wecorroborate by Western blot the presence of PAP inisolated
exosomes produced by stable transfected TMPAP/LNCaP cells.
The results showed the presence of TMPAP as well as snapin in
the exosomal fraction in addition to flotillin and CD13, a
prostasomal marker [35] (Fig. 4F).
Discussion
Prostate cancer is a disease of complex etiology, in which
genetic and epigenetic mechanisms are involved. PAP was the first
prostate cancer marker, and its usefulness was based in the
assessment of its serum activity levels. We have previously shown
that in addition to the secretory PAP, a transmembrane isoform is
widely expressed in different mouse organs such as prostate,
salivary glands, thymus, lung, kidney and brain, amongst others.
TMPAP is also present in androgen sensitive prostate cancer cells
(LNCaP), but absent in androgen insensitive prostate cancer cells
(PC3) [5].
In all the PAP2/2 mice, progressive changes were observed in
the prostatic tissue leading to the development of prostate
adenocarcinoma at the age of 12 months. Despite the presence
of prostate cancer, we have not detected any metastatic lesions.
Histologically, the mouse DLP has been considered to be the
analogous area to the peripheral zone of the human prostate,
where the majorities of adenocarcinomas reside [36]. In this
regard, Roy-Burman et al. suggested that the mouse models
carrying genetic modifications that affect the tumor development
in the DLP are more significant for the studies on those
pathologies associated with the peripheral zone of the human
prostate [37].
In humans, it has been observed that PTEN (phosphatase and
tensin homolog deleted on chromosome 10) is downregulated in
prostate cancer tissue specimens [38]. PTEN antagonize PI3K
(phosphoinositol 3-kinase) activity by dephosphorylating phos-
phoinositol (3,4,5)-triphosphate which is an activator of the AKT
pathway leading to cell survival. The PTEN prostate cancer
mouse model showed a development of prostate cancer which
resembles the stages of the disease in humans, starting with
hyperplasia at 4 weeks of age, mPIN, prostate microinvasive
adenocarcinoma in all prostatic lobes and finally metastasizing in
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different organs at 12 weeks of age [39]. However, the genetic
background of the mouse might affect the phenotype. The pattern
of the disease progression described in the PTEN mouse model is
observed in mice of mixed genetic background. However, when a
more homogeneous genetic background (up to eight backcrossing
in C57BL/6 strain) was studied, mPIN appeared at 2 month of
age and invasive adenocarcinoma at 12 months, nevertheless no
metastatic lesions were observed [40]. The deficiency of PAP
expression in our mice leads to a similar phenotype than that
observed inPTEN-deficient mouse model of prostate cancer both
with the same genetic background (C57BL/6). The only difference
between these mouse models is that there are no pathological
changes in VP lobe of PAP2/2 mice.
The ultrastructural studies of PAP2/2 mouse prostates showed
a high amount of nanovesicles, compatible in size with exosomes.
According to this finding, other authors have reported a significant
increment of exosomes in plasma of prostate cancer patients
compared to healthy donors or benign hyperplasia [14]. In
addition, King et al. showed that augmented levels of hypoxia
inside solid tumors increased the release of exosomes [41]. Flotillin
as well as bis-(monoacylglycero)-phosphate (BMP or LBPA) are
present in exosomes [42], and previously we have shown that PAP
co-localized with flotillin in LNCaP cells and with BMP in human
prostate cancer samples [5]. We now confirm the presence of
TMPAP inexosomes from TMPAP/LNCaP cells; in addition
these exosomes also containedsnapin, flotillin and CD13. The
microarray results indicate significant changes in the expression of
genes related to the release of neurotransmitters and vesicular
traffic in prostates of PAP2/2 mice. The interaction between
TMPAP and snapin detected in LNCaP cellsisanindication that
disturbed exocytosis is involved in the phenotype we observed.
The vesicular traffic is an intrinsic factor in the regulation of cell
polarity, which is gaining attention as a determinant of tumor
development [43]. Recently, exosomes and exosome-like vesicles
received increased attention in relation to tumor development and
progression. In particular, the release of exosomes containing
biologically active molecules, such as microRNAs, DNAs, RNAs
and proteins, has been reported to have an impact on cell-cell
communication. The above mentioned tumor suppressor PTEN is
exported in exosomes while maintaining its phosphatase activity in
the recipient cells [12], this could imply that cells which do not
express certain protein could obtain it from others.
Our results in addition to our previous knowledge of the presence
of PAP in the endosomal-lysosomal pathway [5] highlight a new
role for PAP in prostatic vesicular traffic which has not been
described before. Considering the topology of TMPAP, this enzyme
cannot exert cytosolic acid phosphatase activity and consequently it
is not able to dephosphorylate cytosolic tyrosines of epidermal
growth factor receptor (EGFR) as it has been previously suggested
[7]. Therefore, we assume this is not the pathway leading to the
observed prostate adenocarcinoma in the PAP2/2 mice.
In Figure 7, we summarize our hypothesis about the modulatory
effect of TMPAP on endo-/exocytosis and the mechanisms
involved in the physical interaction between TMPAP and snapin.
Previous reports have showed that the interaction of membrane
proteins with snapin negatively regulates exocytosis by affecting
the coupling of synaptotagmin to the SNARE complex [44] or by
reducing snapin phosphorylation [45] which is needed to strength
the interaction between synaptotagmin and Snap25. The phos-
phorylation of snapin by the cyclic adenosine monophosphate
(cAMP)-dependent kinase PKA is crucial step for SNARE
assembly in pancreatic b-cells leading to glucose-induced exocy-
tosis [29]. Our results are consistent with these findings, and we
built a mechanistic model representing the interaction between
TMPAP and snapin. According to Buxton et al., 70% of snapin is
found in the cytosol [46] where its phosphorylation by PKA occurs
[47]. This process would be delayed if snapin is bound to TMPAP
and could be a first regulatory effect on secretion. A second effect
could involve the 59-ectonucleotidase activity of TMPAP respon-
sible for the production of adenosine from AMP [19]. Adenosine
receptors are G-protein couple receptors (GPCRs) known to
regulate neurotransmission/exocytosis [48]. In this case, adenosine
could bind to its cognate receptors A1, A2 and A3 that modulate
cAMP levels [49,50] consequently modifying the PKA activity and
snapin phosphorylation status. Moreover, the interaction between
TMPAP and snapin at the plasma membrane could block the
interaction between the cytosolic YxxW motif in TMPAP and the
adaptor protein complex-2 required for clathrin-based endocytosis
[51]. This effect could delay the internalization of TMPAP and
extend the time that TMPAP is present in the cellular surface
eliciting its catalytic activity and producing a sustained adenosine
effect on adenosine receptors.
According to this model, the lack of TMPAP would lead to the
observed dysregulation of vesicular traffic, exocytosisand release of
exosomes in PAP2/2 mouse prostate. This could establish a
significant starting point for uncontrolled cell proliferation and the
development of prostate adenocarcinoma. Interestingly, in DRG
of PAP2/2 mice the levels of PI (4,5) P2 are increased when
compared to wild-type mice [21]. Considering that PI (4,5) P2 is
the main regulator for clathrin-based endocytosis [20], our
observations of increased exocytosis in prostates of PAP2/2 mice
requires a concomitant increased endocytosis mechanism to keep
the cell membrane homeostasis.
In summary, this PAP2/2 mouse model shows that TMPAP is
required for the normal function of prostate in mice, and its
deficiency leads to prostate adenocarcinoma. This suggests that
TMPAP acts as a regulator of endo-/exocytosis mechanism.
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